| Document |
Document Title |
|
WO/2005/012228A1 |
The invention relates to novel o ptical recording materials that comprise specific and in some cases novel diketone enamines or metal chelates thereof and that have excellent recording and playback quality especially ata wavelength of 35...
|
|
WO/2005/009940A1 |
The invention provides novel compounds according to formula I relates to compounds with the general formula I said compounds being useful, e.g. in the treatment of inflammatory, ophthalmic diseases or cancer.
|
|
WO/2005/000795A2 |
This invention relates to aniline derived non-steroidal compounds that are or are believed to be modulators of androgen, glucocorticoid, mineralocorticoid, and progesterone receptors, and also to the methods for the making and use of suc...
|
|
WO/2004/108680A1 |
[PROBLEMS] To provide an industrially advantageous process for the production of important mother-nucleus intermediates of antibacterial agents and intermediates for the production thereof. [MEANS FOR SOLVING PROBLEMS] A process for the ...
|
|
WO/2004/099262A1 |
The Invention relates to novel ketones of formulae (I) and (II) wherein R1, R2, R3 and R4 are, for example, Cl-C8alkyl, R5 is, for example, hydrogen, A is CI, Br, -0-R7, -NR8R9 or -S-R16, A' is -O-, -NH- or -NR8-, X and Y are each indepe...
|
|
WO/2004/089873A1 |
Process for crystallising Bupropion hydrochloride comprising the following stages: a) Bupropion hydrochloride is dissolved in a mixture comprising methanol and a precipitating solvent for Bupropion hydrochloride; b) any insoluble residue...
|
|
WO/2004/083336A2 |
The present invention provides functional finishing dyes comprising at least one functional finishing group covalently attached to a traditional dye via a chemical linkage. More particularly, the present invention provides novel antimicr...
|
|
WO/2004/073642A2 |
The present invention provides a combinatorial approach to a library of novel compounds having four diversity points. The compounds provide for the mapping of urotensin II and somatostatin 5 receptors by differential binding of said rece...
|
|
WO/2004/071434A2 |
The present invention is directed novel compounds which are derivatives of minocycline or doxycycline, pharmaceutical compositions containing same and use thereof in lowering excess IgE levels in a mammal suffering from a disease where I...
|
|
WO/2004/071401A2 |
A compound having the following formula (I): wherein R1 is lower alkyl optionally substituted with one or more suitable substituent(s); aryl optionally substituted with one or more suitable substituent(s); or fused ring, R2 is acylamino ...
|
|
WO/2004/065401A1 |
This invention relates to a new class of polyene polyketides, their pharmaceutically acceptable salts and derivatives, and to methods for obtaining the compounds. One method of obtaining these compounds is by cultivation of novel strains...
|
|
WO/2004/058691A1 |
This disclosure describes antifungal antibiotics designated Hygroscopene A, Hygroscopene B and Hygroscopene C to their production by fermentation, to methods for recovery and concentration from the crude solutions, to a process for purif...
|
|
WO/2004/056762A2 |
The invention provides novel compounds according to formula (I) relates to compounds with the general formula (I), said compounds being useful, e.g. in the treatment of inflammatory diseases.
|
|
WO/2004/056365A2 |
A compound of formula (I): wherein R1, R2, R3 and Y are as defined herein, or a pharmaceutically-acceptable and -cleavable ester, or acid addition salt thereof, useful for promoting the release of parathyroid hormone, e.g. for preventing...
|
|
WO/2004/054982A1 |
Disclosed are novel biphenylcarboxamides of formula (I), wherein R, Z, X, Y, m, n, and A have the meanings indicated in the description, several methods for producing said substances, the use thereof for controlling undesired microorgani...
|
|
WO/2004/052359A1 |
Methods are disclosed for inhibiting or disrupting Janus tyrosine kinase 3 (Jak3) dependent function in cells of lymphoid or myeloid origin, especially for blocking proliferation and function of lymphocytes (e.g., T-cells, B-cells). A Ma...
|
|
WO/2004/043921A1 |
A novel, improved, and general process for the preparation of 4-aryl-3-hydroxymethyl-1-methylpiperidines is disclosed in the present invention. 4-(4-Fluorophenyl)-3-hydroxymethyl-1-methylpiperidine is a well-known intermediate in making ...
|
|
WO/2004/040534A2 |
β-diketone fluorescent tags are disclosed, particularly those enabling the use of excitation energy in the near visible or visible spectrum. In some cases, these tags allow the use of cost-effective excitation devices such as LED’s. T...
|
|
WO/2004/026804A1 |
The invention provides novel anthraquinone compositions that are useful as broad-spectrum quenchers of fluorescence and provides methods for making and using them. The anthraquinone quenchers can be conjugated to a variety of biologicall...
|
|
WO/2004/026850A1 |
The present invention relates to processes for the preparation of 2-amino-4,5,6,7-tetrahydro-6-aminobenzothiazoles (5a) from cyclohexanes (2a) and cyclohexanones (3a) as intermediate.
|
|
WO/2004/026817A1 |
An amino alcohol derivative represented by the general formula (1): (1) &lcub e.g., (±)-2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-
methylpentan-1-ol&rcub . It has excellent immunosuppressive activity and is reduced in side ...
|
|
WO/2004/024674A1 |
This invention is related to the preparation of bupropion hydrochloride. The reaction of 3'-chloropropiophenone with bromine in presence of tert-butylamine to prepare the bupropion free base and then recovering of bupropion hydrochloride...
|
|
WO/2004/020391A1 |
The invention relates to monoalkylamino ketones of formula (I), wherein R1 and R2 have the meanings as cited in the description.
|
|
WO/2004/014550A2 |
The invention relates to novel monocarbene complexes of nickel, palladium or platinum containing electron-deficient olefin ligands, to their production and to the use thereof in the homogeneous catalysis of organic reactions (Formula II ...
|
|
WO/2004/013077A2 |
A compound of formula (I) or (II): wherein A is hydrogen or CR1R2; Y and Z are each, independently, hydrogen or a halogen; X is -NR4R5, or R7; R1 is hydrogen, or a substituted or unsubstituted alkyl or alkenyl group containing 1-4 carbon...
|
|
WO/2004/011410A1 |
Compounds of formula (I):wherein variable groups are as defined within; for use in the inhibition of 11$g(b)HSD1 are described.
|
|
WO/2004/011418A1 |
Disclosed are novel compounds of the formula (I)or a pharmaceutically acceptable salt or solvate thereof. Also disclosed is the treatment of chemokine-mediated diseases using compounds of the formula (II)
|
|
WO/2004/007426A1 |
The invention relates to fullerene compounds of formula (I); in which X1, X2, X3, X4, X5, YI, Y2, V, W, F, E, R, r, n, p, and q are defined as in the specification. Also disclosed are pharmaceutical compositions containing one of the com...
|
|
WO/2004/005239A1 |
The invention relates to a process for the synthesis of N-monosubstituted β-amino alcohols of formula (I) and/or an addition salt of a proton acid, wherein R1 and R2 independently represent alkyl, cycloalkyl, aryl or aralkyl, each being...
|
|
WO/2004/002947A1 |
Compounds of formula (I), wherein R01 is hydrogen, C1-C8alkyl, C3-C8alkenyl or C3-C8alkynyl; or R01 is phenyl or phenyl-C1-C6alkyl, it being possible for the phenyl rings in turn to be mono- to penta-substituted by halogen and/or mono-, ...
|
|
WO/2003/106399A2 |
The invention provides processes for preparing N-protected β-amino aldehyde compounds which are useful as synthetic intermediates for preparing glycopeptide antibiotic derivatives. The processes include cleaving a carbon-carbon double b...
|
|
WO/2003/104186A1 |
A process for easily producing, from an easily available inexpensive starting material, an optically active ß-amino alcohol useful as an intermediate for medicines. An easily available &agr -substituted ketone is reacted with an optical...
|
|
WO/2003/101933A1 |
Novel solid supported intermediate products of the general formula I coupled to a solid polymeric support through one or both of the R&supl groups or through the R4 group which are suitable for synthesis of heterocyclic compounds are dis...
|
|
WO/2003/099769A1 |
The present invention is directed to selective LXR modulators, small molecule compounds corresponding to Formula I and is further directed to a process of treating a condition in a mammal that is modulated by LXR using a therapeutically ...
|
|
WO/2003/097577A1 |
The invention relates to a filtering composition, particularly a cosmetic composition, which is used to protect a sensitive material against ultraviolet radiation, one such composition comprising an effective quantity of at least one nit...
|
|
WO/2003/097568A1 |
A process for producing a 4-phenyl-4-oxo-2-butenoic ester derivative, characterized by simultaneously or continuously reacting a sulfuric ester, aromatic hydrocarbon, and maleic anhydride derivative. By the process, a 4-phenyl-4-oxo-2-bu...
|
|
WO/2003/097575A2 |
The invention provides novel amino-functionalised chalcone derivatives and analogues thereof. Use of the compounds, or compositions comprising them, as pharmaceutically active agents, in particular against bacterial and parasitic infecti...
|
|
WO/2003/097576A2 |
The invention provides novel diamino-functionalised chalcone derivatives and analogues thereof. Use of the compounds, or compositions comprising them, as pharmaceutically active agents, in particular against bacterial and parasitic infec...
|
|
WO/2003/097574A2 |
The invention provides novel alkoxyaminochalcone derivatives and analogues thereof. Use of the compounds, or compositions comprising them, as pharmaceutically active agents, in particular against bacterial and parasitic infections, is al...
|
|
WO/2003/091200A1 |
A process for the preparation of 2-aminoketones represented by the general formula (3): (3) [wherein R is halogeno, cyano, C1-12 alkyl, or the like; R2 is hydrogen or C1-6 alkyl; n is an integer of 0 to 5; and R1 is hydrogen or C1-12 alk...
|
|
WO/2003/086340A1 |
The present invention relates to organosilicone derivatives of amino hydroxybenzophenones, a process for their preparation thereof, a cosmetic compositions comprising the organosilicone derivative and the use thereof for protecting hair ...
|
|
WO/2003/087034A1 |
The invention relates to 3-aminophenol derivatives of formula (I) or to their physiologically compatible, water-soluble salts, wherein R1 is identical to a radical of formula (II) or to a radical of formula (III), and to dyes that contai...
|
|
WO/2003/087035A1 |
2,5-bis-diamine-[1,4]benzoquinonic derivatives, having a general formula (I) have proved useful for the treatment of Alzheimer's disease; a method for preparing them and intermediates used in said method are also described. Fomula (I).
|
|
WO/2003/086605A2 |
One aspect of the present invention relates to ionic liquids comprising a pendant Bronsted-acid group, e.g., a sulfonic acid group. Another aspect of the present invention relates to the use of an ionic liquid comprising a pendant Bronst...
|
|
WO/2003/078387A1 |
A compound of formula (I): in which A is a C alkylene group with a chain length between NH and N(O)R'R' of at least 2 carbon atoms and R' and R' are each separately selected from C1-4 alkyl groups and C2-4 hydroxyalkyl and C2-4 dihydroxy...
|
|
WO/2003/068731A1 |
The invention relates to beta-amino ketones of general formula (I), in which R1-R4 are defined as per the description. The invention also relates to a method for the production, in particular stereoselective production of said beta-amino...
|
|
WO/2003/059339A1 |
Novel tricyclic−bis−enone derivatives (TBEs) as well as the process for the preparation of such TBEs are provided. Also provided are methods for prevention and&sol or treatment of cancer, Alzheimer's disease, Parkinson's disease, mul...
|
|
WO/2003/048106A2 |
The invention concerns 1,3-diarylprop-2-en-1-ones and derivatives, compositions containing same and the use thereof. The invention concerns in particular novel substituted 1,3-diarylprop-2-en-1-ones having a therapeutic activity for use ...
|
|
WO/2003/048096A1 |
The invention concerns products of formula (I), wherein: A represents a saturated or partly saturated cyclic hydrocarbon, optionally substituted; X is selected from the group consisting of O, N-O(R2); Ar1 represents a substituted phenyl ...
|
|
WO/2003/040174A2 |
The present invention relates to compounds of the general formula (I): B-(CH--R?1¿)¿n?--C(=X?2¿)-D and pharmaceutically acceptable salts thereof including steroisomers, to the use of the compounds for the treatment of impaired glucose...
|
